VALIDATED EXECUTIVE ENGAGEMENTS
POOL + OUTREACH
4113
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
741
Interactions with Platform & by Email
PARTICIPANTS
123
Unique # Participated
VALIDATIONS
56
Responses Validated*
* Login to view program details and full enterprise executive list.
DATE
AUGUST 2020
TABLES
108
PAGES
193
EDITION
16
PRICE
USD $5450
The World of Biopharmaceutical Bioseparation Systems is Changing Fast!
It's Time to Identify Upcoming Revenue Pockets & Growth Areas.
COVID-19 IMPACT SURVEY
GLOBAL EXECUTIVE SURVEY
Impact of Pandemic & Economic Slowdown
Monitor Market Dynamics!
Early March 2020, we reached out to senior enterprise executives who are driving strategy, business development, marketing, sales, product management, technology and operations at competitive firms worldwide. Our ongoing survey is focused on how this will this affect their business ecosystems. We invite you to participate in our survey and add to collective perspectives. Market movements are tracked for 2020, 2021 and broadly for the period of 2022 through 2025. Critical changes are monitored dynamically for the rest of this year. Updated analytics will reflect new and evolving market realities. Our first update scheduled for May 2020 and another in the Fall. Clients receive complimentary updates during 2020. If your company is a recent client for this project, we may have already reached out to your colleagues to participate in our program. If you're an active player in the space but hasn't yet subscribed to our project, we invite you to participate and share your perspectives. Please sign-up here.
Amid the COVID-19 crisis, the global market for Biopharmaceutical Bioseparation Systems estimated at US$7.1 Billion in the year 2020, is projected to reach a revised size of US$12.6 Billion by 2027, growing at aCAGR of 8.4% over the period 2020-2027. Chromatography, one of the segments analyzed in the report, is projected to record 8% CAGR and reach US$6.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Other Technologies segment is readjusted to a revised 8.8% CAGR for the next 7-year period.
The Biopharmaceutical Bioseparation Systems market in the U.S. is estimated at US$1.9 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.9 Billion by the year 2027 trailing a CAGR of 12.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.6% and 7.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.4% CAGR.We bring years of research experience to this 16th edition of our report. The 193-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
3M Purification Inc.; Agilent Technologies, Inc.; Alfa Wassermann Separation Technologies LLC; Flottweg Separation Technology; GE Healthcare Life Sciences; GEA Westfalia Separator Group GmbH; KNAUER Wissenschaftliche Geräte GmbH; Konik Nanobiotech SL; Merck KGaA; Pall Corporation; ProMetic Life Sciences Inc.; Repligen Corp.; Sartorius Stedim Biotech; Thermo Fischer Scientific Inc.; Tosoh Bioscience Inc.; YMC Europe GMBH
» Technology (Chromatography, Other Technologies)
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa
INSIDER ACCESS PRIVILEGES
Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.
KEY DIFFERENTIATORS
We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.
* A review of 262 off-the-shelf market report publishers worldwide.
WHAT SETS US APART
Client companies can access multiple features on our MarketGlassâ„¢ platform.
Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.
Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)
A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.
Where relevent and possible we present competitive brands.
Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.
Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.
Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.
We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.
Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.
All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.
05
| I. INTRODUCTION, METHODOLOGY & REPORT SCOPE |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Bioseparation Systems - Invaluable Tools in Biopharmaceutical Manufacturing |
| Recent Market Activity |
| US Remains Market Leader; Developing Countries to Drive Market Growth |
| Chromatography Leads the Pack |
| Global Market for Gas Chromatography Systems |
| Competitive Landscape |
| A Peek into Biopharmaceutical Manufacturing |
| Downstream Processing of Biosynthetic Products - An Overview |
| Growing Biopharmaceutical Market Drives Demand for Bioseparation Systems |
| New Biologic License Application (BLA) Approvals-2017 |
| New Biologic License Application (BLA) Approvals: 2016 |
| New Biologic License Application (BLA) Approval: 2015 |
| Biopharmaceutical Industry Transforms Downstream Processing |
| Growing Biological Drug Manufacturing Capacity to Drive Growth |
| Growing Market for Monoclonal Antibodies - A Key Review of Current Status and Future Prospects |
| Approved Monoclonal Antibodies: 2014-2017 |
| An Insight into Bioseparation of mAbs |
| Growing Biosimilars Market - A Clear Advantage for Bioseparation Technologies |
| Patent Expiries of Major Biopharmaceutical Drugs in the US and Europe |
| US APPROVED BIOSIMILARS AS OF DECEMBER 2017 |
| EUROPE APPROVED BIOSIMILARS AS OF DECEMBER 2017 |
| R&D Funding Crucial for Biologics and Bioseparation Market |
| Huge Biopharmaceutical Pipeline - A Clear Indicator of Future Prospects |
| Global Competitor Market Shares |
| Biopharmaceutical Bioseparation Systems Competitor Market Share Scenario Worldwide (in %): 2018 & 2029 |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3M Company (USA) |
| 3M Purification, Inc. (USA) |
| Agilent Technologies, Inc. (USA) |
| Alfa Wassermann Separation Technologies, LLC (USA) |
| Flottweg Separation Technology (USA) |
| GEA Westfalia Separator Group GmbH (Germany) |
| GE Healthcare Life Sciences (USA) |
| KNAUER Wissenschaftliche Geräte GmbH (Germany) |
| Konik Nanobiotech SL (Spain) |
| Merck KGaA (Germany) |
| Pall Corporation (USA) |
| ProMetic Life Sciences, Inc. (Canada) |
| Sartorius Stedim Biotech (France) |
| Repligen Corporation (USA) |
| Thermo Fisher Scientific, Inc. (USA) |
| Tosoh Bioscience, Inc. (Japan) |
| YMC Europe GmbH (Germany) |
| 3. MARKET TRENDS & DRIVERS |
| Increasing Need for Further Advances in Downstream Processing Techniques |
| Process Optimization and Cost Reduction - Key Goals of Innovations in Bioseparation |
| Continuous Bioseparation Gains Momentum |
| Process Intensification |
| Single-Use Systems Play a Key Role |
| Minimizing Centrifugation Steps |
| Integration of Down-Stream and Up-Stream |
| Developmental Efforts |
| Focus on Enhancing Capture Increases |
| Introduction of Diversified Resins on the Rise |
| Multicolumn System Lower Buffer and Resin Requirement |
| Single-Use Disposable Technologies Gain Attention |
| Select Commercial Disposable/Single-Use Technologies by Process Technique |
| Innovations in Single-use Systems |
| Increasing Biopharma Productivity and Efficiency via Continuous Manufacturing |
| Changing Paradigm of Primary Recovery in Bioseparation |
| Growing Use of Membrane Filtration in Biopharmaceutical Manufacturing |
| Chromatography - The Gold Standard Purification Technology |
| Continuous Chromatography - A Key Technology for the Biopharma Sector |
| Challenges to Separate Active Pharmaceutical Ingredients, Chromatography to the Rescue |
| Inherent Benefits of Membrane Chromatography to Drive its Use in Bioprocessing |
| SMBC - An Old Approach Gaining Significant Attention |
| Superior Efficiency Drives Use of Synthetic Ligands in Affinity Chromatography |
| A Comparison of Protein and Synthetic Ligands |
| Increasing Alternatives to Protein A Column based Capturing |
| Twin-Column SMB - An Emerging Alternative to Protein A Columns |
| Chiral Chromatography Increases in Popularity |
| Flexible and Selective Chromatography Improves Biopharmaceutical Efficiencies |
| Chromatography Efficiency and Selectivity |
| Mixed-Mode Chromatography |
| Multimode Chromatography |
| Mixed-Mode and Multimode Media Offer Cost Savings |
| Awareness of Mixed Mode and Multimode Media Operating Modes Critical |
| Magnetic Separation as an Alternative to Chromatography - A Review |
| Reversible Precipitation - A Novel Bioseparation Technology |
| 4. GLOBAL MARKET PERSPECTIVE |
| Biopharmaceutical Bioseparation Systems Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025 |
| Biopharmaceutical Bioseparation Systems Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017 |
| Biopharmaceutical Bioseparation Systems Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025 |
| Chromatography (Technology) World Market by Region/Country in US$ Million: 2018 to 2025 |
| Chromatography (Technology) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017 |
| Chromatography (Technology) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025 |
| Other Technologies (Technology) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025 |
| Other Technologies (Technology) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017 |
| Other Technologies (Technology) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025 |
| III. MARKET ANALYSIS |
| GEOGRAPHIC MARKET ANALYSIS |
| United States |
| Market Facts & Figures |
| US Biopharmaceutical Bioseparation Systems Market Share (in %) by Company: 2018 & 2025 |
| Biopharmaceutical Bioseparation Systems Market in US$ Million in the United States by Technology: 2018-2025 |
| United States Biopharmaceutical Bioseparation Systems Market Retrospective Analysis in US$ Million by Technology: 2009-2017 |
| United States Biopharmaceutical Bioseparation Systems Market Share Breakdown by Technology: 2009 VS 2019 VS 2025 |
| Canada |
| Biopharmaceutical Bioseparation Systems Market Analysis in Canada in US$ Million by Technology: 2018-2025 |
| Biopharmaceutical Bioseparation Systems Market in Canada: Historic Review in US$ Million by Technology for the Period 2009-2017 |
| Canadian Biopharmaceutical Bioseparation Systems Market Share Breakdown by Technology: 2009 VS 2019 VS 2025 |
| Japan |
| Japanese Medium & Long-Term Outlook for Biopharmaceutical Bioseparation Systems Market in US$ Million by Technology: 2018-2025 |
| Biopharmaceutical Bioseparation Systems Market in Japan in US$ Million by Technology: 2009-2017 |
| Japanese Biopharmaceutical Bioseparation Systems Market Percentage Share Distribution by Technology: 2009 VS 2019 VS 2025 |
| China |
| Biopharmaceutical Bioseparation Systems Market Estimates and Forecasts in China in US$ Million by Technology: 2018-2025 |
| Chinese Biopharmaceutical Bioseparation Systems Retrospective Market Scenario in US$ Million by Technology: 2009-2017 |
| Biopharmaceutical Bioseparation Systems Market in China: Percentage Share Analysis by Technology for 2009, 2019, and 2025 |
| Europe |
| Market Facts & Figures |
| European Biopharmaceutical Bioseparation Systems Market: Competitor Market Share Scenario (in %) for 2018 & 2025 |
| European Biopharmaceutical Bioseparation Systems Market Demand Scenario in US$ Million by Region/Country: 2018-2025 |
| Biopharmaceutical Bioseparation Systems Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017 |
| European Biopharmaceutical Bioseparation Systems Market Share Shift by Region/Country: 2009 VS 2019 VS 2025 |
| European Biopharmaceutical Bioseparation Systems Market Assessment in US$ Million by Technology: 2018-2025 |
| European Biopharmaceutical Bioseparation Systems Historic Market Review in US$ Million by Technology: 2009-2017 |
| Biopharmaceutical Bioseparation Systems Market in Europe: Percentage Breakdown of Sales by Technology for 2009, 2019, and 2025 |
| France |
| French Biopharmaceutical Bioseparation Systems Market Estimates and Projections in US$ Million by Technology: 2018-2025 |
| French Biopharmaceutical Bioseparation Systems Historic Market Analysis in US$ Million by Technology: 2009-2017 |
| French Biopharmaceutical Bioseparation Systems Market Share Breakdown by Technology: 2009 VS 2019 VS 2025 |
| Germany |
| German Biopharmaceutical Bioseparation Systems Latent Demand Forecasts in US$ Million by Technology: 2018-2025 |
| Biopharmaceutical Bioseparation Systems Market in Germany: A Historic Perspective by Technology in US$ Million for the Period 2009-2017 |
| German Biopharmaceutical Bioseparation Systems Market Share Breakdown by Technology: 2009 VS 2019 VS 2025 |
| Italy |
| Biopharmaceutical Bioseparation Systems Market Estimates and Forecasts in Italy in US$ Million by Technology: 2018-2025 |
| Italian Biopharmaceutical Bioseparation Systems Retrospective Market Scenario in US$ Million by Technology: 2009-2017 |
| Biopharmaceutical Bioseparation Systems Market in Italy: Percentage Share Analysis by Technology for 2009, 2019, and 2025 |
| United Kingdom |
| United Kingdom Medium & Long-Term Outlook for Biopharmaceutical Bioseparation Systems Market in US$ Million by Technology: 2018-2025 |
| Biopharmaceutical Bioseparation Systems Market in the United Kingdom in US$ Million by Technology: 2009-2017 |
| United Kingdom Biopharmaceutical Bioseparation Systems Market Percentage Share Distribution by Technology: 2009 VS 2019 VS 2025 |
| Spain |
| Biopharmaceutical Bioseparation Systems Market Analysis in Spain in US$ Million by Technology: 2018-2025 |
| Biopharmaceutical Bioseparation Systems Market in Spain: Historic Review in US$ Million by Technology for the Period 2009-2017 |
| Spanish Biopharmaceutical Bioseparation Systems Market Share Breakdown by Technology: 2009 VS 2019 VS 2025 |
| Russia |
| Biopharmaceutical Bioseparation Systems Market in US$ Million in Russia by Technology: 2018-2025 |
| Russian Biopharmaceutical Bioseparation Systems Market Retrospective Analysis in US$ Million by Technology: 2009-2017 |
| Russian Biopharmaceutical Bioseparation Systems Market Share Breakdown by Technology: 2009 VS 2019 VS 2025 |
| Rest of Europe |
| Rest of Europe Biopharmaceutical Bioseparation Systems Market Assessment in US$ Million by Technology: 2018-2025 |
| Rest of Europe Biopharmaceutical Bioseparation Systems Historic Market Review in US$ Million by Technology: 2009-2017 |
| Biopharmaceutical Bioseparation Systems Market in Rest of Europe: Percentage Breakdown of Sales by Technology for 2009, 2019, and 2025 |
| Asia-Pacific |
| Asia-Pacific Biopharmaceutical Bioseparation Systems Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025 |
| Biopharmaceutical Bioseparation Systems Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017 |
| Asia-Pacific Biopharmaceutical Bioseparation Systems Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025 |
| Asia-Pacific Biopharmaceutical Bioseparation Systems Market Estimates and Projections in US$ Million by Technology: 2018-2025 |
| Asia-Pacific Biopharmaceutical Bioseparation Systems Historic Market Analysis in US$ Million by Technology: 2009-2017 |
| Asia-Pacific Biopharmaceutical Bioseparation Systems Historic Market Analysis in US$ Million by Technology: 2009 VS 2019 VS 2025 |
| Australia |
| Australian Biopharmaceutical Bioseparation Systems Latent Demand Forecasts in US$ Million by Technology: 2018-2025 |
| Biopharmaceutical Bioseparation Systems Market in Australia: A Historic Perspective by Technology in US$ Million for the Period 2009-2017 |
| Australian Biopharmaceutical Bioseparation Systems Market Share Breakdown by Technology: 2009 VS 2019 VS 2025 |
| India |
| Biopharmaceutical Bioseparation Systems Market Analysis in India in US$ Million by Technology: 2018-2025 |
| Biopharmaceutical Bioseparation Systems Market in India: Historic Review in US$ Million by Technology for the Period 2009-2017 |
| Indian Biopharmaceutical Bioseparation Systems Market Share Breakdown by Technology: 2009 VS 2019 VS 2025 |
| South Korea |
| Biopharmaceutical Bioseparation Systems Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Technology for the Period 2018-2025 |
| South Korean Biopharmaceutical Bioseparation Systems Historic Market Analysis in US$ Million by Technology: 2009-2017 |
| Biopharmaceutical Bioseparation Systems Market Share Distribution in South Korea by Technology: 2009 VS 2019 VS 2025 |
| Rest of Asia-Pacific |
| Rest of Asia-Pacific Medium & Long-Term Outlook for Biopharmaceutical Bioseparation Systems Market in US$ Million by Technology: 2018-2025 |
| Biopharmaceutical Bioseparation Systems Market in Rest of Asia-Pacific in US$ Million by Technology: 2009-2017 |
| Rest of Asia-Pacific Biopharmaceutical Bioseparation Systems Market Percentage Share Distribution by Technology: 2009 VS 2019 VS 2025 |
| Latin America |
| Latin American Biopharmaceutical Bioseparation Systems Market Trends by Region/Country in US$ Million: 2018-2025 |
| Biopharmaceutical Bioseparation Systems Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017 |
| Latin American Biopharmaceutical Bioseparation Systems Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025 |
| Biopharmaceutical Bioseparation Systems Market Estimates and Forecasts in Latin America in US$ Million by Technology: 2018-2025 |
| Latin American Biopharmaceutical Bioseparation Systems Retrospective Market Scenario in US$ Million by Technology: 2009-2017 |
| Biopharmaceutical Bioseparation Systems Market in Latin America : Percentage Analysis by Technology for 2009, 2019, and 2025 |
| Argentina |
| Argentinean Biopharmaceutical Bioseparation Systems Market Assessment in US$ Million by Technology: 2018-2025 |
| Argentinean Biopharmaceutical Bioseparation Systems Historic Market Review in US$ Million by Technology: 2009-2017 |
| Biopharmaceutical Bioseparation Systems Market in Argentina: Percentage Breakdown of Sales by Technology for 2009, 2019, and 2025 |
| Brazil |
| Brazilian Biopharmaceutical Bioseparation Systems Market Estimates and Projections in US$ Million by Technology: 2018-2025 |
| Brazilian Biopharmaceutical Bioseparation Systems Historic Market Analysis in US$ Million by Technology: 2009-2017 |
| Brazilian Biopharmaceutical Bioseparation Systems Market Share Breakdown by Technology: 2009 VS 2019 VS 2025 |
| Mexico |
| Mexican Biopharmaceutical Bioseparation Systems Latent Demand Forecasts in US$ Million by Technology: 2018-2025 |
| Biopharmaceutical Bioseparation Systems Market in Mexico: A Historic Perspective by Technology in US$ Million for the Period 2009-2017 |
| Mexican Biopharmaceutical Bioseparation Systems Market Share Breakdown by Technology: 2009 VS 2019 VS 2025 |
| Rest of Latin America |
| Biopharmaceutical Bioseparation Systems Market in US$ Million in Rest of Latin America by Technology: 2018-2025 |
| Rest of Latin America Biopharmaceutical Bioseparation Systems Market Retrospective Analysis in US$ Million by Technology: 2009-2017 |
| Rest of Latin America Biopharmaceutical Bioseparation Systems Market Share Breakdown by Technology: 2009 VS 2019 VS 2025 |
| Middle East |
| The Middle East Biopharmaceutical Bioseparation Systems Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025 |
| Biopharmaceutical Bioseparation Systems Market in the Middle East by Region/Country in US$ Million: 2009-2017 |
| The Middle East Biopharmaceutical Bioseparation Systems Market Share Breakdown by Region/Country: 2009, 2019, and 2025 |
| The Middle East Biopharmaceutical Bioseparation Systems Market Analysis in US$ Million by Technology: 2018-2025 |
| Biopharmaceutical Bioseparation Systems Market in the Middle East: Historic Review in US$ Million by Technology for the Period 2009-2017 |
| The Middle East Biopharmaceutical Bioseparation Systems Market Share Breakdown by Technology: 2009 VS 2019 VS 2025 |
| Iran |
| Iranian Medium & Long-Term Outlook for Biopharmaceutical Bioseparation Systems Market in US$ Million by Technology: 2018-2025 |
| Biopharmaceutical Bioseparation Systems Market in Iran in US$ Million by Technology: 2009-2017 |
| Iranian Biopharmaceutical Bioseparation Systems Market Percentage Share Distribution by Technology: 2009 VS 2019 VS 2025 |
| Israel |
| Israeli Biopharmaceutical Bioseparation Systems Market Assessment in US$ Million by Technology: 2018-2025 |
| Israeli Biopharmaceutical Bioseparation Systems Historic Market Review in US$ Million by Technology: 2009-2017 |
| Biopharmaceutical Bioseparation Systems Market in Israel: Percentage Breakdown of Sales by Technology for 2009, 2019, and 2025 |
| Saudi Arabia |
| Biopharmaceutical Bioseparation Systems Market Estimates and Forecasts in Saudi Arabia in US$ Million by Technology: 2018-2025 |
| Saudi Arabian Biopharmaceutical Bioseparation Systems Retrospective Market Scenario in US$ Million by Technology: 2009-2017 |
| Biopharmaceutical Bioseparation Systems Market in Saudi Arabia: Percentage Share Analysis by Technology for 2009, 2019, and 2025 |
| United Arab Emirates |
| Biopharmaceutical Bioseparation Systems Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Technology for the Period 2018-2025 |
| United Arab Emirates Biopharmaceutical Bioseparation Systems Historic Market Analysis in US$ Million by Technology: 2009-2017 |
| Biopharmaceutical Bioseparation Systems Market Share Distribution in United Arab Emirates by Technology: 2009 VS 2019 VS 2025 |
| Rest of Middle East |
| Rest of Middle East Biopharmaceutical Bioseparation Systems Latent Demand Forecasts in US$ Million by Technology: 2018-2025 |
| Biopharmaceutical Bioseparation Systems Market in Rest of Middle East: A Historic Perspective by Technology in US$ Million for the Period 2009-2017 |
| Rest of Middle East Biopharmaceutical Bioseparation Systems Market Share Breakdown by Technology: 2009 VS 2019 VS 2025 |
| Africa |
| Biopharmaceutical Bioseparation Systems Market in US$ Million in Africa by Technology: 2018-2025 |
| African Biopharmaceutical Bioseparation Systems Market Retrospective Analysis in US$ Million by Technology: 2009-2017 |
| African Biopharmaceutical Bioseparation Systems Market Share Breakdown by Technology: 2009 VS 2019 VS 2025 |
| IV. COMPETITION |
| Total Companies Profiled : 61 Click here to request a full table of contents and more details on this project. |
INSIDER ACCESS TO
METHODOLOGY
QUESTIONNAIRE
INFLUENCER NETWORK
Registration is required to access our data stacks.
RESEARCH PANEL
Panelists are carefully chosen based on their domain expertise and market influence.
Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.
Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.
- Complimentary previews of full stack research data for participated
- Insider access to research programs including engagements and stats from other panelists
- Unlimited research credits of $1000 per participated project
- Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
- Interact with other panelists via our MarketGlassTM Data Exchange Platform*
- BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*
* Complete details will be shared with panelists upon formal acceptance.
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com